baber/WOPTO huggingface dataset:
Patent NZ-556099-A (NZ)
Title: Heat shock proteins (hsp) and supraventricular arrhythmia
Inventor: HENNING ROBERT HENK
IPC: A61K38/02
Filed: 2005-12-09
Abstract: Provided is the use of a drug capable of increasing the amount ofHSP27 or a HSP27like protein in a cardiac cell for the manufacture of a medicament for the treatment of a supraventricular arrhythmia. The drug can be geranylgeranylacetone.
Patent NZ-563416-A (NZ)
Title: Electrostatic separation of mineral products with foreign particles being triboelectrically charged
Inventor: MANGELBERGER THOMAS
IPC: B02C23/08
Filed: 2006-05-18
Abstract: A method for manufacturing dispersed mineral products by grinding the mineral raw material, sizing the same in a flow classifier, sorting the same in dispersion in air, and eliminating the dispersion air. The method includes triboelectrically charging the dispersed mineral particles of the particle-air dispersion during the sizing process and directing the charged particles through an electrostatic separation chamber in order to separate the foreign particles from the valuable particles.
Patent NZ-567793-A (NZ)
Title: Food waste disposal unit
Inventor: PAN JI CHENG
IPC: B02C18/00
Filed: 2008-04-29
Abstract: A food waste disposer has a housing 12 defining a grinding chamber 14 having an inlet 16 and an outlet 18. A grinding mechanism including a shredder ring 20 and a grinding disc 22, is disposed within the grinding chamber 14. A liner 21, preferably of a plastics material, extends from the shredder ring 20 to the inlet 16. The liner 21 reduces the noise generated by the disposer when in use.
Patent NZ-568313-A (NZ)
Title: Pharmaceutical compositions comprising buprenorphine
Inventor: SIMMONS ROBERT D
IPC: A61K9/70
Filed: 2006-11-16
Abstract: A pharmaceutically acceptable liquid otic composition for administration to a non-human animal comprising about 0.1 to about 10% by weight buprenorphine, a pharmaceutically acceptable carrier system comprising about 10 to about 80% by weight of a solvent consisting of a water phase and organic phase, and at least one penetration enhancing agent, wherein the at least one penetration enhancing agent consists of propylene glycol monolaurate, wherein the organic phase of the solvent comprises at least one organic solvent selected from the group comprising 2- pyrrolidone, glyceryl formal, dimethylformamide, N-methyl-pyrrolidone, propylene glycol, polyethylene glycol, diethylisosorbide, ethanol, isopropanol, 1,2-propanediol, glycerin, triethyl citrate, benzyl alcohol and dimethylisosorbide, wherein the composition has a pH within the range of about 3.5 to about 6, and wherein said composition is in a single dose form.
Patent NZ-574654-A (NZ)
Title: Crystalline forms of rapamycin analogs
Inventor: VISWANATH SHEKHAR
IPC: A61K31/395
Filed: 2007-07-24
Abstract: Disclosed is a rapamycin analog of formula (I). Also disclosed are crystalline forms of the analogues with powder diffraction patterns as disclosed in the specification; a composition comprising a compound of formula (I); a process for preparing a crystalline form of a compound of formula (I).
Patent NZ-578873-A (NZ)
Title: Complement factor B analogs and uses for the treatment of complement mediated disease such as inflammation
Inventor: KALEKO MICHAEL
IPC: C07K14/47
Filed: 2008-02-29
Abstract: Discloses the use of a complement factor B protein sequence, comprising a mutational change at position 279 or 280 of the protein sequence, for manufacture of a medicament for treating a complement mediated diseases. The medicament further comprises a viral vector encoding the complement factor B protein sequence, or analog, adapted for administration to a subject by a pharmaceutically acceptable carrier. Further disclosed are complement factor B protein sequence variants that are designed to have increased native complement factor B binding affinity. Such variants are directed towards the manufacture of a medicament for treating diseases or conditions related to the eyes.
Patent NZ-580510-A (NZ)
Title: Mammalian-type glycosylation in plants by expression of non-mammalian glycosyltransferases
Inventor: ROUWENDAL GERARD JOHAN ADOLPH
IPC: A01H5/00
Filed: 2008-04-17
Abstract: Disclosed is a method of producing a transgenic plant or a transgenic plant cell which is capable of adding galactose residues in beta1,4-linkage to N-linked glycans, comprising: (a) inserting a nucleic acid molecule into a plant or a plant cell, the nucleic acid molecule comprising a nucleotide sequence coding for a non-mammalian beta1,4-galactosyltransferase selected from the group consisting of: (i) a polypeptide comprising an amino acid sequence at least 85% identical to that of chicken beta1,4-galactosyltransferase comprising the amino acid sequence of SEQ ID NO:2; (ii) a polypeptide comprising a first fragment consisting of an amino acid sequence of about 10-20 amino acids in length corresponding to the N-terminal amino acid sequence of a mammalian beta1,4-galactosyltransferase and a second fragment that is the chicken beta1,4-galactosyltransferase, the first fragment being linked to the N-terminal of the second fragment, and (iii) a polypeptide comprising an amino acid sequence that is otherwise identical to the chicken beta1,4-galactosyltransferase except that the cytoplasmic-transmembrane-stem region (CTS) of the chicken beta1,4galactosyltransferase is replaced by the CTS of a mammalian sialyltransferase or by the CTS of a plant Golgi-Iocalized protein; (b) selecting a transgenic plant or transgenic plant cell that has taken up the nucleic acid molecule of (a); and (c) expressing the nucleic acid molecule, thereby producing a transgenic plant or transgenic plant cell capable of adding galactose residues in beta1,4-linkage to N-linked glycans.
Patent NZ-580659-A (NZ)
Title: Printing process for patterned wrapper paper using a starch solution
Inventor: LI PING
IPC: A24D1/02
Filed: 2008-05-22
Abstract: A process for making patterned wrapper paper comprises the steps of preparing a printing solution including water and an oxidized starch, providing a base web of wrapper paper, and applying the printing solution to the wrapper paper in a predetermined pattern. The starch has a room temperature viscosity no greater than about 50 centipoises (50 mPas), particles in the range of about 4 to about 40 microns when dry and about 90% in the range of about 10 microns to about 100 microns when wet, and a pH in the range of about 6 to about 6.5. The starch is further capable of forming solution with about 20% to about 24% oxidized starch content. The printing solution has a surface tension of at least about 65 dynes per centimeter (6.5 x 10-2 Nm-1 ),
Patent NZ-582559-A (NZ)
Title: Breathable gas patient interface interlocking nasal prongs and frame unit
Inventor: GUNEY MEMDUH
IPC: A61M16/06
Filed: 2008-07-28
Abstract: A breathable gas patient interface (mask) includes a frame 6030 and a nasal prong assembly 6020 including a pair a nasal prongs to provide an effective seal with the patient's nostrils and a frame contacting portion 6029 that is inserted and retained within a frame channel 6032.1 of the frame. The frame contacting portion includes an external protrusion 6029.3 that is adapted to interlock with a corresponding opening 6032.1 provided in the frame channel.
Patent NZ-583012-A (NZ)
Title: Process for the preparation of thiazolopyrimidines
Inventor: BUTTERS MICHAEL
IPC: C07D497/04
Filed: 2004-12-02
Abstract: Disclosed is a thiazolopyrimidine compound of the formula (V) or a pharmaceutically acceptable salt or solvate thereof and wherein R1 has the meaning as stated in the specification.
Patent NZ-590946-A (NZ)
Title: Progestin-containing drug delivery system
Inventor: GENERAL SASCHA
IPC: A61K9/00
Filed: 2009-08-07
Abstract: a) Disclosed herein is a unit dosage form comprising a thin water-soulble film matrix, wherein a) said film matrix comprises at least one water-soluble matrix polymer; b) said film matrix comprises particles where said particles comprises at least one progestin and at least one protective agent, and where said particles have a d90 particle size of ?280µm; c) said film matrix has a thickness of ?300µm; wherein said progestin is selected from the group consisting of levo-norgestrel, norgestrel, norethindrone (norethisterone), dienogest, norethindrone (norethisterone) acetate, ethynodiol diacetate, dydrogesterone, medroxyprogesterone acetate, norethynodrel, allylestrenol, Iynestrenol, quingestanol acetate, medrogestone, norgestrienone, dimethisterone, ethisterone, chlormadinone acetate, megestrol, promegestone, desogestrel, 3-ketodesogestrel, norgestimate, gestodene, tibolone, cyproterone acetate, dienogest and drospirenone, wherein said water-soluble matrix polymer is selected from the group consisting of a cellulosic material, a gum, a protein, a starch, a synthetic polymer, a glucan, and mixtures thereof, and wherein said protective agent is a wax.
Patent NZ-603709-A (NZ)
Title: Rechargeable battery powered utility pump with series centrifugal pump configuration
Inventor: MEZA HUMBERTO V
IPC: F04B39/00
Filed: 2012-11-19
Abstract: 603709 Disclosed is a utility pump with a housing (12) containing a series configuration of integral pumps, and also containing a battery receiving portion configured with a flat wall with electrical terminals arranged thereon for receiving power to the pump . The utility pump also has a battery (14) with a protruding portion configured with a corresponding flat wall having corresponding electrical terminals arranged thereon. The corresponding electrical terminals are configured to contact respectively both of the electrical terminals on the flat wall of the battery receiving portion to provide power from the battery (14) to the pump when the protruding portion of the battery (14) is inserted into the battery receiving portion of the housing and rotated to an “ON” position. The corresponding electrical terminals are also configured not to contact respectively both of the electrical terminals when the battery (14) is rotated from the “ON” position to an “OFF” position.
Patent NZ-607599-A (NZ)
Title: High voltage high current regulator circuit
Inventor: BIRNBACH CURTIS A
IPC: H01J7/16
Filed: 2011-10-05
Abstract: High voltage high current regulator circuit for regulating current is interposed between first and second terminals (13, 15) connected to an external circuit and comprises at least one main-current carrying cold-cathode field emission electron tube (23) conducting current between the first and second terminals (13, 15). First and second grid-control cold-cathode field emission electron tubes (35, 1035) provide control signals for first and second grids of the at least one main-current carrying cold-cathode field emission electron tube for positive and negative excursions of voltage on the first and second terminals (13, 15), respectively. The current regulator circuit may be accompanied by a voltage-clamping circuit that includes at least one cold-cathode field emission electron tube. At least two cold-cathode field emission electron tubes, configured to operate at high voltage and high current, are preferably contained within a single vacuum enclosure and are interconnected to provide a circuit function, so as to form a high voltage high current vacuum integrated circuit.
Patent NZ-608407-A (NZ)
Title: Improvements in bird-proofing
Inventor: ALAN HARRY NEWMAN
IPC: E04C3/07
Filed: 2013-03-18
Abstract: A method of bird-proofing a metal purlin of substantially a channel or C shape. The method involves wedging a non-structural insert (9)between the lowermost flange (4) and the internal surface (17) of the base (16). The non-structural insert is adapted to provide an inclined face preventing or deterring birds from perching on it. The insert may be provided with a hooked edge (10) adapted to co-act with a lip (8) of the metal purlin.
Patent NZ-611660-A (NZ)
Title: A fish filleting machine
Inventor: JACOBSEN PREBEN HOLM
IPC: A22C25/16
Filed: 2011-06-20
Abstract: Fish filleting machine comprising a number of stations arranged in sequence for continuous filleting of fish, where the de-capitated and gutted fish is placed right side up, i.e. the back of the fish upwards and front end foremost in an in-feed channel where the machine further comprises: - a first station comprising means for engaging the fish and centering said fish relative to a vertical plane of the machine, such that lower sides of the fish are arranged on opposite sides of said plane; - a second station comprising means for detecting and registering the vertical extent of the lower edges of the fish and the back of the fish; - a third station comprising means for fixating the back of the fish, and cutting means for cutting slits in the back of the fish, said slits having an extent at least along either side of the protruding back fin; - a fourth station comprising articulated cutting means, where said articulated cutting means are arranged on either side of the vertical plane, suitable for cutting/trimming at least a part of the lowermost sides and/or edges of the fish; - a fifth station where upper cutting means are positioned along the vertical plane for cutting the fish meat free from the vertebrae of the fish; - a sixth station comprising means for cutting vertically on either side of the vertebrae; - a seventh station for directing the bone-free fillets to further processing.
Patent NZ-619618-A (NZ)
Title: Swivel elbow and connector assembly for patient interface systems
Inventor: BARLOW ADAM FRANCIS
IPC: A61M16/08
Filed: 2012-07-06
Abstract: A swivel elbow and connector assembly (10) for a patient interface system, comprising: a ring (20) configured to be sealingly secured in an aperture of the patient interface system, the ring including a first side in an interior of the patient interface system and a second side at an exterior of the patient interface system when the ring is secured in the aperture, the ring comprising a plurality of vents (21) configured to permit flow of gases from the interior to the exterior of the patient interface system; and an elbow (40) swivelably secured in the ring. The ring comprises a first flange (22) on the first side and a second flange (23) on the second side, the first and second flanges defining a channel (24) that sealingly engages the aperture of the patient interface system. Vented gas is prevented from flowing between the ring and the elbow. The elbow and the portion of the ring between the first and second flanges form a ball and socket connection in which the portion of the ring between the first and second flanges has an elbow-facing surface with an arcuate cross-section and the elbow has a ring-facing surface with an arcuate cross-section.
Patent NZ-627151-A (NZ)
Title: Tube support
Inventor: GEOFFREY BRYAN MACKNEY
IPC: A41D13/00
Filed: 2014-07-07
Abstract: Disclosed is a support (100) in the form of a harness for supporting a portion of a feeding tube. The disclosure notes that typically adhesive tape is used to secure a free end of a feeding tube which is surgically embedded in patient. Adhesive tape can cause tearing and irritation to a patients skin. The support (100) includes a torso embracing portion (10) and one or more tube holding portions. The torso embracing portion (10) embraces a torso of the patient. The one or more tube holding portions hold the tube and are fixable to, or part of, the torso embracing portion (10). The support (100) is configured to embrace the tube at differing locations spaced across the patient’s chest to accommodate variation in the location and orientation at which the tube is at least partially embedded.
Patent NZ-628916-A (NZ)
Title: Removable adapter for air and fuel intake and mixing in a combustion tool
Inventor: RICORDI CHRISTIAN
IPC: F02M35/024
Filed: 2013-04-02
Abstract: Disclosed is a fuel can adaptor that is removable from the combustion fastener driving tool to allow replacement of the fuel and air filters. The adapter for external air and fuel intake and mixing in an internal combustion fixing tool that comprises a combustion chamber, is arranged to be mounted in the tool, and to be connected to a fuel cartridge and to receive fuel and communicate with the combustion chamber so as to inject a mixture of external air and fuel therein. An air intake manifold is provided for bringing external air in the combustion chamber of the tool and a fuel pathway for bringing fuel from a fuel cartridge to the combustion chamber. A venturi is provided, being arranged to drive external air admitted in the adapter and mix it with the fuel. The adapter is housed within the tool.
Patent NZ-701370-A (NZ)
Title: Il-6 binding molecules
Inventor: BLANCHETOT CHRISTOPHE
IPC: C07K16/24
Filed: 2013-05-23
Abstract: The present invention provides binding molecules (e.g., antibodies or antigen binding fragments thereof) that specifically bind to and inhibit the biological activity of IL-6 (e.g., human, mouse and non-human primate IL-6) with high affinity and low immunogenicity. In a preferred embodiment, the antibodies or antigen binding fragments of the invention bind to IL-6 and inhibit its binding to an IL-6 receptor. Such antibodies or antigen binding fragments can be used for treating IL-6-associated diseases or disorders (e.g., inflammatory disease and cancer).
Patent NZ-701898-A (NZ)
Title: Drug delivery composition
Inventor: KEWALRAMANI RAJ
IPC: A61K9/50
Filed: 2010-04-08
Abstract: Disclosed is a multiparticulate composition comprising a plurality of beads, each bead comprising: an inert substrate or core; a solubilizing agent in the form of a surface active agent or a pH modulator disposed about the inert substrate or between the semi-permeable layer and the medicament layer, a semipermeable coating; particles of a medicament said particles having an effective average particle size of less than or about 2 μm and a surface stabilizer adsorbed on the surface of the medicament particles. Further disclosed are the methods for making composition in the form of a multiparticulate dosage form, comprising: contacting particles of medicament with at least one surface stabilizer for a time and under conditions sufficient to provide medicament particles having an effective average particle size of less than or about 2 μm; and forming a plurality of beads, each bead comprising: an inert core; a layer of solubilizing agent; a layer of the medicament particles; and a semipermeable coating as the outermost layer.
Patent NZ-706775-A (NZ)
Title: Methylene linked quinolinyl modulators of ror-gamma-t
Inventor: LEONARD KRISTI
IPC: A61P29/00
Filed: 2013-10-15
Abstract: The present invention comprises compounds of Formula (I), wherein: R1, R2, R3, R4, R5, R6, R7, R8, and R9 are defined in the specification. The invention also comprises a method of treating or ameliorating a syndrome, disorder or disease, wherein said syndrome, disorder or disease is rheumatoid arthritis or psoriasis. The invention also comprises a method of modulating RORγt activity in a mammal by administration of a therapeutically effective amount of at least one compound of claim 1.
Patent NZ-716341-A (NZ)
Title: Glyceride composition
Inventor: GAMBELLI LUISA
IPC: A23L33/00
Filed: 2014-07-31
Abstract: A composition for use in developing and/or improving brain function comprises a glyceride having a palmitoyl group at the 2- position wherein at least 40% by weight of the palmitic acid content of the composition is present as palmitoyl groups bonded at the 2- position of a glyceride.
Patent NZ-720969-A (NZ)
Title: Octahydro fused azadecalin glucocorticoid receptor modulators
Inventor: HUNT HAZEL
IPC: C07D471/04
Filed: 2014-11-21
Abstract: The present invention provides octahydro fused azadecalin compounds of formula (I) having glucocorticoid receptor binding affinity and modulatory activity for pharmaceutical use. Also provided are pharmaceutical compositions containing an effective amount of the fused azadecalin compounds and methods of using the compositions for the-treatment of a glucocorticoid receptor mediated disorder in a subject.
Patent NZ-723399-A (NZ)
Title: Methods and compositions for dna profiling
Inventor: STEPHENS KATHRYN
IPC: C12Q1/686
Filed: 2015-02-13
Abstract: Embodiments disclosed herein provide methods for constructing a DNA profile comprising: providing a nucleic acid sample, amplifying the nucleic acid sample with a plurality of primers that specifically hybridize to at least one target sequence comprising a SNP and at least one target sequence comprising a tandem repeat, and determining the genotypes of the at least one SNP and at least one tandem repeat in the amplification products, thereby constructing the DNA profile of the nucleic acid sample. Embodiments disclosed herein further provide a plurality of primers that specifically hybridize to at least one short target sequence and at least one long target sequence in a nucleic acid sample, wherein amplifying the nucleic acid sample using the plurality of primers in a single reaction results in a short amplification product and a long amplification product, wherein each of the plurality of primers comprises one or more tag sequences. Each of the plurality of primers has a melting temperature that is less than 58 degrees C, has a length of at least 24 nucleotides that hybridize to the target sequence, and is AT rich with an AT content of at least 40%.
Patent NZ-741393-A (NZ)
Title: Treatment of nervous system disorders using combinations of rxr agonists and thyroid hormones
Inventor: CHANDRARATNA ROSHANTHA
IPC: C07C57/03
Filed: 2016-10-31
Abstract: There is a need for compositions and methods for treating nervous system disorders, such as by inducing remyelination and neuroprotection. In this context, the present invention relates to use of a RXR agonist in the manufacture of a medicament for the treatment of a nervous system disorder in an individual, wherein the medicament is adapted for administration with a thyroid hormone selected from thyroxine and triiodothyronine, wherein the selective RXR agonist is 3,7-dimethyl-6(S),7(S)-methano,7-[1,1,4,4-tetramethyl-1,2,3,4-tetrahydronaphth-7-yl]2(E),4(E) heptadienoic acid, bexarotene, or LG268, and wherein the combination of RXR agonist and thyroid hormone causes a greater improvement in the nervous system disorder than the selective RXR agonist or thyroid hormone alone.
Patent NZ-748966-A (NZ)
Title: Functionalized benzamide derivatives as antiviral agents against hbv infection
Inventor: XU XIAODONG
IPC: A61P31/12
Filed: 2013-12-05
Abstract: Novel functionalized benzamide derivatives of formula (V) are provided. Also provided are pharmaceutical compositions comprising therapeutically effective amounts of functionalized benzamide derivatives useful as pregenomic RNA encapsidation inhibitors, useful for the treatment of Hepatitis B virus (HBV) infection, in combination with at least one pharmaceutically acceptable excipient.
Patent NZ-775125-A (NZ)
Title: Nasal assembly
Inventor: JUDSON DANIEL ROBERT
IPC: A61M16/06
Filed: 2006-10-13
Abstract: A patient interface for delivering a supply of pressurized breathable gas to a patient, the patient interface comprising: a cushion configured to form a seal around an opening to a patient’s airways; and a support structure connected to the cushion, the support structure and the cushion together defining a breathing chamber, the support structure including a vent including a plurality of vent holes configured to provide gas-washout of exhaled gas in the breathing chamber, the support structure having increased rigidity as compared to the cushion; an inlet elbow configured to provide fluid communication between an air delivery tube and the breathing chamber; and a removable component attached to the support structure, the removable component including a window that is aligned with the plurality of vent holes, the window surrounds the plurality of vent holes and is configured to receive there-through the gas-washout from the plurality of vent holes in use after exiting from the plurality of vent holes.